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BACKGROUND: Obtaining accurate blood pressure (BP) readings is a
challenge faced by health professionals. Clinical trials implement strict
protocols, whereas clinical practices and studies that assess quality of
care utilize a less rigorous protocol for BP measurement.
OBJECTIVE: To examine agreement between real-time clinic-based
assessment of BP and the standard mercury assessment of BP.
DESIGN: Prospective reliability study.
PATIENTS: One hundred patients with an International Classification
of Diseases—9th edition code for hypertension were enrolled.
MEASURES: Two BP measurements were obtained with the Hawksley
random-zero mercury sphygmomanometer and averaged. The clinic-
based BP was extracted from the computerized medical records.
RESULTS: Agreement between the mercury and clinic-based systolic
blood pressure (SBP) was good, intraclass correlation coefficient
(ICC)=0.91 (95% confidence interval (CI): 0.83 to 0.94); the agreement
for the mercury and clinic-based diastolic blood pressure (DBP) was
satisfactory, ICC=0.77 (95% CI: 0.62 to 0.86). Overall, clinic-based
readings overestimated the mercury readings, with a mean overesti-
mation of 8.3 mmHg for SBP and 7.1 mmHg for DBP. Based on the
clinic-based measure, 21% of patients were misdiagnosed with uncon-
trolled hypertension.
CONCLUSIONS: Health professionals should be aware of this potential
difference when utilizing clinic-based BP values for making treatment
decisions and/or assessing quality of care.
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O btaining accurate blood pressure (BP) readings is im-portant for the management and assessment of hyper-
tension. Clinical trials implement a strict protocol designed to
minimize observer bias.1 However, in clinical practice and in
studies that assess quality of care, a less rigorous protocol is
used to obtain BP values.2 The lack of rigorous BP measure-
ments in the clinical setting may lead to unreliable recordings
and misunderstandings of patients’ BP control. This may in-
fluence medication recommendations as well as assessments
of clinic-based quality of care.
Historically, the random-zero mercury sphygmomanome-
ter has been the gold standard for BP measurements. However,
owing to concern over mercury spills, the mercury devices are
no longer used in the clinical setting.3 In 1998, the American
Hospital Association (AHA) and the Environmental Protection
Agency (EPA) signed a memorandum of understanding to elim-
inate mercury from hospitals by 2005 and launched a program
to assist hospitals in this process.4 Consequently, mercury
sphygmomanometers are being replaced with other BP devic-
es. Although these devices have been compared with the mer-
cury sphygmomanometer under strict conditions, their utility in
routine clinical practice has not been thoroughly investigated.5
Our study evaluated the current state of the clinic-based
method of BP measurement. We sought to quantify the degree
of agreement between real-time primary care clinic-based as-




The study was conducted in the general internal medicine
practice at Duke University Medical Center. Patients of 3 gen-
eral internal medicine physicians, who had an International
Classification of Diseases—9th edition diagnosis of hyperten-
sion (401.9) and an upcoming primary care clinic appoint-
ment, were contacted for participation in the study.
Approximately 392 patients received a letter 2 weeks prior to
their appointment. Of these, 227 were reached by telephone
for screening 1 week prior to their appointment. Patients were
excluded if they were on dialysis; had recently been hospital-
ized for heart attack, stroke, or metastatic cancer; lived in a
nursing home; or received home health care. The exclusion
criteria were for a separate study. Eligible patients were sched-
uled to meet with a research assistant 60 minutes prior to their
physician’s visit. If patients were unable to meet before, they
were scheduled to meet with a research assistant directly after
their physician’s visit. One hundred patients consented and
participated in the study.
Procedure
The protocol was approved by Duke University’s Institutional
Review Board. A trained research assistant performed all
standard BP assessments. First, the patient’s arm circum-
ference was measured at the arm’s mid-point between the
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acromium and olecranon process. The proper size cuff was
placed on the right arm of the patient. Patients were instructed
to sit up straight, with their back against the chair, their feet
flat on the floor, and the cuffed arm resting on the table at
heart level. At this point, the research assistant left the room,
allowing the patients to relax for 5 minutes. Upon returning,
the research assistant obtained 2 BP measurements with the
mercury device. Between measurements, patients were asked
to raise their arm for 5 seconds and rest their arm at heart level
for an additional 25 seconds. Finally, a brief interview was
conducted to obtain demographic information.
Three research assistants were involved in this study.
Each research assistant received training and certification
for the use of the random-zero mercury sphygmomanometer
by successfully completing 4 items: a videotape exam; a writ-
ten exam; a demonstration of the technique and procedure for
proper BP measurement; and a Y-tube stethoscope exam. We
examined whether there were differences in systolic (SBP) or
diastolic blood pressure (DBP) by aresearch assistant using
analysis of variance. The effect of research assistant on di-
astolic BP (mean of observations 1 and 2) assessed with the
mercury device was significant (P=.02). However, further in-
spection of the data revealed that two patient outliers drove the
effect. When the outliers were excluded, there was no longer a
significant effect by research assistant (P=.11). Excluding the
2 outliers did not significantly affect the intraclass correlation
coefficient (ICC) values; therefore, we retained all patients in
the analyses.
Clinic-Based Measurement
The general internal medicine clinic utilized either of the fol-
lowing BP devices: the Welch Allyn vital signs monitor 52000
series (an oscillometric device) or the Tycos wall aneroid
sphygmomanometer. Nurses obtained patients’ BP in the ex-
amination room before the physician’s encounter and recorded
them in the facility charts and the electronic medical records.
We extracted the clinic-based BP from the patients’ electronic
medical records. Eighty-four percent of the clinic-based as-
sessments occurred within 1 hour of the standard mercury
assessment. The mean time difference between the standard
assessment and the clinic-based readings was 24 minutes
(SD=47 minutes).
Statistical Analysis
Systolic and diastolic readings were obtained for 199 of the
200 possible measurements with the mercury device. The
missing datapoint was because of large arm size.
We examined the extent to which two different methods of
BP assessment (mercury vs clinic) produce the same BP values
in 3 ways. First, we plotted the mean of the 2 methods (X-axis)
against the difference between the 2 methods (Y-axis).6 This
Bland–Altman graphical representation permits investigation
of the strength of the relationship (i.e., correlation) as well as
the extent of agreement (i.e., the extent to which the 2 methods
produce the exact same measurements). When 2 methods
have high correlation but poor agreement, this nature of dis-
agreement is displayed by the Bland–Altman graph. If agree-
ment between 2 methods is high, then the difference scores
should be normally distributed about a mean of zero. Second,
we calculated the ICCs, which assess the relationship between
2 or more variables that have the same metric and variance.7
We used a 2-way mixed model without interaction, treating
mode of assessment (i.e., mercury vs clinic) as a fixed variable
and subjects as a random variable. Third, we calculated the
k for percent of BPs in control versus out of control according
to type of assessment (mercury vs clinic-based) using the Joint
National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure (JNC 7) guidelines to define
control.8
RESULTS
Patients’ ages ranged from 43 to 86 years. The majority were
female (77%), 78% were white, and 20% were black. Approx-
imately one-quarter were diabetic and 94% were prescribed
one or more antihypertensive medications (Table 1).
Agreement Between Mercury and Clinic-Based
Measurements
The agreement between mercury and clinic-based readings
was good for SBP, ICC=0.91 (95% confidence interval (CI):
0.83, 0.94), and satisfactory for DBP, ICC=0.77 (95% CI: 0.62,
0.86). The nature of disagreement is reflected in the Bland–
Altman graphs, which show that the clinic-based assessments
tended to overestimate both SBP and DBPs obtained by mer-
cury. The mean difference was 8.3 mmHg (SD=13) for SBP
and 7.1 mmHg (SD=12) for DBP (see Fig. 1). The ICC estimate
of agreement between mercury and clinic-based DBP readings
was lower than that for SBP readings because of a smaller
range of DBP values.
















Calcium channel blocker 35
ACE inhibitor 47
b-Blocker 26




Arm circumference (cm) (R: 24 to 49) 34 (5)
BP measurements (mmHg)
Mercury SBP (R: 84 to 186) 128 (20)
Mercury DBP (R: 30 to 106) 67 (13)
Clinic-based SBP (R: 99 to 188) 136 (18)
Clinic-based DBP (R: 52 to 108) 74 (11)
Kidney disease defined by serum creatinine 41.5 for males, 41.3 for
females.
ACE, angiotensin-converting enzyme inhibitors; BP, blood pressure; SBP,
systolic blood pressure; DBP, diastolic blood pressure; R, range.
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We also determined agreement between methods within cate-
gories of BP control as defined by JNC 7. Twenty-three percent
of the patients were classified with controlled BP (o140/80, or
o130/80 for patients with diabetes or renal disease) based on
the clinic as well as the mercury readings. Fifty-two percent
were classified with uncontrolled BP based on the clinic as well
as the mercury readings. However, 21% of the patients were
characterized with uncontrolled BP based on clinic measure-
ments, while their standard mercury assessment of BPs showed
that they were in control. When categorized in this manner,
agreement between clinic-based and standard methods was
only moderate, k=0.47 (95% CI: 0.30, 0.64).9
DISCUSSION
The gold standard for BP measurement is the utilization of the
mercury sphygmomanometer and a strict protocol. In clinical
practice, however, an aneroid or a digital device is used under
a less stringent protocol. When the two types of assessment
were compared, we found that clinic-based readings were gen-
erally higher than the values obtained using the more rigorous
method. The Bland–Altman graphs specify the nature of disa-
greement (see Fig. 1). Specifically, clinic-based assessments
tended to overestimate both SBP and DBP obtained by mer-
cury. Of note, the clinic overestimation occurred more often
with mercury readings categorized as normotensive. Hence,
although the patients’ BP values may be normal based on the
mercury device, the clinic-based readings misdiagnosed 21%
of the patients with uncontrolled BP.
Our study had several limitations. First, the clinic-based
readings and the standard assessments were not taken at the
same time. However, the majority of the readings (84%) oc-
curred within 1 hour of each other. Second, we did not ran-
domize the order of physician’s visit and research assistant’s
meeting. However, patients who met with the research assist-
ant before their physician’s visit (N=86) did not have more el-
evated clinic BPs than patients who met with the research
assistant after their physician’s visit (N=14). Third, there was
the potential for terminal digit bias by the research assistants
when using the random-zero mercury sphygmomanometer.
However, each research assistant was trained to perform BP
measurements by decreasing the mercury column by 2 mmHg
per second to prevent digit preference. On the other hand, the
potential for terminal digit preference in the clinic could not be
controlled. Therefore, we would consider this a characteristic
of the less rigorous protocol carried out in the clinic.
In summary, we show evidence that the assessment of
BPs in a primary care clinic fails to provide values that are
obtained with a standard method of assessment. Furthermore,
clinic-based BP values may overestimate those obtained by a
standard method. The degree of overestimation is clinically
important and could result in inappropriate treatment deci-
sions. We advocate better standardization of the clinic-based
method with implementation of recommended devices and a
more rigorous training of the nursing staff.
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FIGURE 1. Bland–Altman graphs comparing blood pressure values
obtained by the random-zero mercury sphygmomanometer ver-
sus the clinic-based method: (A) systolic blood pressures; (B) di-
astolic blood pressures.
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